Skip to main content

Table 4 Adequacy of antibiotic treatment and 28-day mortality per risk category of the abbMEDS and CURB-65

From: Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study

n (%)

Low risk

Intermediate risk

High risk

 

Patients

Mortality

Patients

Mortality

Patients

Mortality

AbbMEDS

 Adequate*

60 (65.9)

1 (1.7)

80 (80.8)

13 (16.3)

13 (92.9)

6 (46.2)

 Inadequate

31 (34.1)

1 (3.2)

19 (19.2)

5 (26.3)

1 (7.1)

1 (100)

 Total (204)#

91 (44.6)

2 (2.2)

99 (48.5)

18 (18.2)

14 (6.9)

7 (50.0)

CURB-65

 Adequate

61 (70.1)

4 (6.6)

43 (70.5)

3 (7.0)

58 (84.1)

15 (25.9)

 Inadequate

26 (29.9)

1 (3.8)

18 (29.5)

5 (27.8)

11 (15.9)

1 (9.1)

 Total (217)#

87 (40.1)

5 (5.7)

61 (29.5)

8 (13.1)

69 (31.8)

16 (23.2)

  1. #The totals are depicted to show how many data were available for all patients
  2. *p = 0.04 for trend. Adequacy was defined as in vitro susceptibility of the identified microorganisms for the empirical treatment